Bright News

Mumbai, November 28, 2025 : Shares of Sudeep Pharma, which is a technology-led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries, debuted on the exchange to close at a 30.5% premium. The scrip listed at Rs 734 and Rs 730 per share on the BSE and NSE respectively. Immediately after the listing, the stock showed impressive upside movement and closed the day with a premium. The company’s share price closed at Rs 773.7 per share on the BSE, a 30.5% premium, and at Rs 771.9 per share on the NSE, a 30.2 % premium. As per NSE, the total quantity traded stood at 397.5 lakh shares, on BSE the total Quantity stood at 48.9 lakh shares. Total Turnover (BSE+NSE) on Day 1 stood at Rs 3,406.9 crore. The Market Capitalisation of the Company at today’s closing price stood at Rs 8,738 crore as per BSE and Rs 8,717.9 crore as per NSE. The company had offered Rs 895 crore issue for subscription from November 21 to November 25. This garnered substant...

Mumbai | November 28, 2025:   Bayer, a global enterprise with core competencies in the life science fields of agriculture and healthcare, announces the launch of   “Nativo® – Make Them Shine,”   a social impact initiative created to open new learning pathways for children in India’s farming communities.   This program is rooted in a simple belief — every child, no matter where they are born, deserves the chance to discover their potential. Through immersive and experiential learning, the initiative supports rural youth in building confidence, curiosity and the skills that shape promising futures. For over 15 years, Bayer’s flagship fungicide brand  Nativo®  has earned the trust of India’s growers by offering reliable, uncompromising crop protection and helping deliver “Grain Shining” across thousands of farms. With this initiative, Nativo® extends its purpose beyond crops — from enabling shining harvests to inspiring shining futures. It reflects the brand’s...

Collaboration to facilitate advanced biologics testing by providing HCP coverage, characterization and quantification assays, and related services to customers globally New center will help improve safety, efficacy, and quality in biopharma development Combination of Cytiva's analytical technologies with Veeda's extensive service delivery capabilities and regulatory expertise November 28, 2025:  Cytiva, a Danaher company and a leader in the life sciences industry, is collaborating with Veeda Lifesciences (Veeda Clinical Research Limited), a global contract research organization, to establish a dedicated Host Cell Protein (HCP) Services Center in Bengaluru, India. Focused on impurity analysis and HCP testing, this new center will help biopharmaceutical companies reduce development risks and meet regulatory standards for novel biologics and biosimilars. Dr. Mahesh Bhalgat, Group CEO and Managing Director, Veeda Lifesciences (Veeda Clinical Research Limited), says: “We are delight...

Mumbai, 26 th  November 2025:  The much-anticipated 21st edition of Clean India Show, India’s only integrated exhibition dedicated to cleaning, hygiene, industrial cleaning and linen care, has officially opened  today  at the Bombay Exhibition Centre, Mumbai. The event is co-located with Laundrex India, a specialised platform focused on linen care solutions. Together, these shows bring an unparalleled showcase of innovation and expertise under one roof from 26 to  28 November 2025 . The expansive show floor will host vibrant displays from over 600 leading brands representing diverse segments such as robotic cleaning solutions, measurable air quality systems, facility management software and automation, green cleaning chemicals, waterless hygiene and sanitation products, surface maintenance, city cleaning systems, waste management solutions, vehicle care tools, and hygienic linen, laundry, and dry-cleaning innovations. The show was inaugurated in the august prese...

Mumbai,  November 26, 2025 :   Utkarsh Small Finance Bank Limited (Utkarsh SFBL)  today  announced a strategic partnership with Axis Securities to provide end-to-end trading and investment services for its customers.  This collaboration marks a significant step in expanding the Bank’s capabilities to deliver next-generation financial solutions. This partnership introduces a unique 3-in-1 account, seamlessly integrating a Savings Account with Utkarsh Small Finance Bank and a Demat and Trading Account with Axis Securities.  This offering is designed to provide customers with a convenient and comprehensive platform for banking and investing. Aligned with Utkarsh Small Finance Bank’s strategy to offer a full spectrum of financial services—including savings and current accounts, deposits, loans, insurance, and investment products—the partnership with Axis Securities will enable customers to seamlessly integrate banking and investing through multiple channels suc...

The Initial Public Offering of Sudeep Pharma was subscribed a massive 93.71 times on the final day of bidding. The issue received bids of 99,00,86,575 shares against the offered 1,05,64,926 equity shares, at a price band of ₹563-593, according to the data available on the stock exchanges. Qualified Institutional Buyer Portion and Non-Institutional Investors Portion were subscribed 213.1 times and 116.7 times respectively, whereas Retail Portion was subscribed 15.65 times.  The issue kicked off for subscription on Friday, November 21, 2025 and closed for subscription on  Tuesday, November 25, 2025 . ICICI Securities and IIFL Capital Services Ltd  are the book-running lead manager; and MUFG Intime India Private Limited is the registrar of the offer. Company Information The company is a technology-led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and is dedicated to contributing to the glob...

India’s first ever index fund designed to track the Nifty MidSmallcap 400 Index – a diversified benchmark combining the Nifty Midcap150 and Nifty Smallcap 250 indices. NFO opens on 24th November and closes on  05th December Investment amount starts from INR 100. India,  25 November 2025 :  Navi AMC, a subsidiary of Navi Limited ( formerly Navi Technologies Limited ), announced the launch of the Navi Nifty MidSmallcap 400 Index Fund, an open-ended index fund that seeks to replicate and track the Nifty MidSmallcap 400 Index. The index represents the combined universe of mid-cap and small-cap companies as defined within the broader Nifty 500. The New Fund Offer (NFO) opens on 24th November 2025 and closes on 5th December 2025. Fund & Index Overview The Scheme will replicate the Nifty MidSmallcap 400 Total Return Index, a free-float market capitalization-weighted index comprising 400 companies (150 mid-cap and 250 small-cap stocks). The index is maintained and rebalanced ...

Mumbai,  November 25 :  Sahajanand Medical Technologies has received final approval from the capital markets regulator, Securities and Exchange Board of India (SEBI), for its initial public offering (IPO). The Company had filed its IPO papers with Sebi on July 25, 2025. The IPO consists of an offer-for-sale of shares of up to 27,644,231 Equity Shares of face value of ₹1 each by promoters - Shree Hari Trust, Dhirajkumar Savjibhai Vasoya and Samara Capital Markets Holding Limited. Other investors selling shares are Kotak Pre-IPO Opportunities Fund and NHPEA Sparkle Holding B V. Incorporated in 2001, the company is a Class III and Class C/D medical devices company with a portfolio of technologically advanced medical devices across vascular and structural heart intervention. According to F&S Report, the company was the first player globally to receive a CE certification for a DES with a biodegradable polymer (Infinnium). Over the years, the company has introduced innovative pr...